#bioweapon

We hereby DEMAND that you IMMEDIATELY CEASE AND DESIST using any of your platforms to promote and/or place Remdesivir/Veklury® in front of viewers in any way.

New England Journal of Medicine in which Remdesivir was pulled from Ebola Controlled Trials because of the high death rates, in which approximately 53% of those receiving the experimental and toxic drug dies. This study was funded and/or supported by the NAIAD, the NIH, the WHO, the DHHS, the DARPA arm of the DOD, and of course Gilead Sciences.